Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Interest Expenses (2016 - 2022)

Niagen Bioscience (NAGE) has disclosed Interest Expenses for 11 consecutive years, with $5000.0 as the latest value for Q3 2022.

  • On a quarterly basis, Interest Expenses fell 66.67% to $5000.0 in Q3 2022 year-over-year; TTM through Jun 2023 was $5000.0, a 88.1% decrease, with the full-year FY2021 number at $55000.0, down 22.54% from a year prior.
  • Interest Expenses was $5000.0 for Q3 2022 at Niagen Bioscience, down from $10000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $575000.0 in Q2 2019 to a low of -$27000.0 in Q3 2018.
  • A 5-year average of $71000.0 and a median of $15000.0 in 2021 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: plummeted 160.0% in 2018, then soared 1262.96% in 2019.
  • Niagen Bioscience's Interest Expenses stood at -$27000.0 in 2018, then soared by 74.07% to -$7000.0 in 2019, then soared by 328.57% to $16000.0 in 2020, then plummeted by 43.75% to $9000.0 in 2021, then tumbled by 44.44% to $5000.0 in 2022.
  • Per Business Quant, the three most recent readings for NAGE's Interest Expenses are $5000.0 (Q3 2022), $10000.0 (Q2 2022), and $8000.0 (Q1 2022).